Neuroone Medical Technologies Corp (NMTC) - Total Liabilities

Latest as of March 2026: $2.49 Million USD

Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has total liabilities worth $2.49 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore NMTC net asset momentum to track the company's year-over-year net asset growth rate.

Neuroone Medical Technologies Corp - Total Liabilities Trend (2010–2025)

This chart illustrates how Neuroone Medical Technologies Corp's total liabilities have evolved over time, based on quarterly financial data. See NMTC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Neuroone Medical Technologies Corp Competitors by Total Liabilities

The table below lists competitors of Neuroone Medical Technologies Corp ranked by their total liabilities.

Company	Country	Total Liabilities
TPC Co. Ltd KQ:130740	Korea	₩26.85 Billion
Orege Société Anonyme PA:OREGE	France	€60.58 Million
Eagle Plains Resources Ltd. V:EPL	Canada	CA$1.66 Million
Sahathai Terminal Public Company Limited BK:PORT	Thailand	฿1.74 Billion
Acrinova AB ST:ACRI-A	Sweden	Skr453.97 Million
Denali Capital Acquisition Corp. Class A Ordinary Shares NASDAQ:DECA	USA	$11.16 Million
Magnum Ventures Limited NSE:MAGNUM	India	Rs5.24 Billion

Liability Composition Analysis (2010–2025)

This chart breaks down Neuroone Medical Technologies Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Neuroone Medical Technologies Corp (NMTC) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuroone Medical Technologies Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuroone Medical Technologies Corp (2010–2025)

The table below shows the annual total liabilities of Neuroone Medical Technologies Corp from 2010 to 2025.

Year	Total Liabilities	Change
2025-09-30	$3.71 Million	-18.36%
2024-09-30	$4.55 Million	+146.11%
2023-09-30	$1.85 Million	-42.58%
2022-09-30	$3.22 Million	+132.43%
2021-09-30	$1.38 Million	-48.60%
2020-09-30	$2.69 Million	+52.16%
2019-09-30	$1.77 Million	-61.64%
2018-09-30	$4.61 Million	+351.02%
2017-09-30	$1.02 Million	+1127.83%
2016-09-30	$83.33K	+134.11%
2015-09-30	$35.59K	+23.14%
2014-09-30	$28.91K	+57.48%
2013-09-30	$18.36K	0.00%
2012-09-30	$18.36K	+7.16%
2011-09-30	$17.13K	+27.33%
2010-09-30	$13.45K	--

About Neuroone Medical Technologies Corp

NASDAQ:NMTC USA Medical Devices

Market Cap

$14.57 Million

Market Cap Rank

#26026 Global

#5379 in USA

Share Price

$1.69

Change (1 day)

-0.59%

52-Week Range

$0.59 - $5.11

All Time High

$26.97